Oxidative DNA Damage is Reduced by a Daily Micronutrient Supplement in HD Patients Dr Mary...
-
Upload
darrell-willis -
Category
Documents
-
view
224 -
download
0
Transcript of Oxidative DNA Damage is Reduced by a Daily Micronutrient Supplement in HD Patients Dr Mary...
Oxidative DNA Damage is Reduced by a Daily Micronutrient
Supplement in HD Patients
Dr Mary Hannon-Fletcher
2nd International Vitamin Conference 23rd May 2012 Copenhagen
Background
End stage renal disease is associated with an increase in oxidative stress, cardiovascular disease and cancer
Haemodialysis induces repetitive bouts of oxidative stress Resulting in increased levels of reactive oxygen species Leading to increased levels of oxidative DNA damage and
thus genomic instability May impact on the elevated levels of cancer reported in HD
patients
Diet in HD Patients
Malnutrition is prevalent in 40-50% Very restricted diets resulting in regulation of
certain nutrients such as:• sodium, potassium, phosphate, protein & fluids
Reduction or exclusion of certain foods increases the risk of inadequate intakes
Under-nutrition exacerbates oxidative stress Together with the increased losses of essential
minerals and water-soluble vitamins via HD Many studies have reported HD patients deficient
in several important vitamins
Aim Using a novel micronutrient supplement containing physiological levels of folate, B, C and E -vitamins, and micronutrientsTo determine if a 3 month placebo controlled intervention would effect levels of DNA damage
Data in our lab showed HD patients had significantly elevated levels of DNA damage compared to age and gender matched controls
Background
Study Design
Baseline Clinical History & Blood Sample
Treatment
n =18
Treatment
n =18
Thirty Nine Participants RecruitedThirty Nine Participants Recruited
3 month intervention 3 month intervention
n=16n=16
Placebo
n=19
Placebo
n=19
n = 15n = 15
Post Intervention Clinical History & Blood Sample
Randomised to treatment
Randomised to treatment
Participants and Methods
Ethical permission was obtained from ORECNI and Governance was obtained from the WHSCT
DNA Damage was measured using the Comet assay (% tail DNA)• Oxidative specific DNA damage measured using bacterial enzymes:
• Endonuclease III (Endo III)• Formamidepyrimidine DNA glycosilase (FPG)
Supplements were provided monthly in a bottle by the pharmacist Volunteers were withdrawn if less than 90% of the supplements were
taken
The Comet Assay
Assessment of DNA Damage
The Comet assay is a Single Cell Microelectrophoretic method for the quantitative measurement of DNA damage and alkali labile sites.
Damaged cells have the appearance of a comet with a tail owing to extension of the DNA towards the anode
(Mc Kelvey Martin et al., Mut Res 288 (1993) 47-63).
Characteristic Placebo
(n=19)
Treatment
(n=18)
Age (years) 62.58 ± 10.95 64.89 ± 8.29
Male/Female
(n/n)
12/7 10/8
Diabetes (n (%)) 6 (31.6%) 7 (38.9%)
Dialysis Duration
(months)
27.00 ± 17.75 27.33 ± 38.09
BMI (kg/m2) 27.08 ± 6.43 26.29 ± 4.80
Table 1: Volunteer Baseline Characteristics
Values are presented as mean ± SD
Figure 2 Changes in DNA Damage in Treatment Group Post Intervention
% T
ail D
NA
*** *** ***
Values are mean ± SD *p>0.001
Table 2: DNA Damage in Placebo Group
% Tail DNA Alkaline FPG ENDO III
Baseline 19.42 ± 8.64 23.38 ± 9.28 23.33 ± 9.64
3 Months 33.81** ± 9.52 30.44* ± 9.77 35.26* ± 9.01
.
Values are mean ±SD **p>0.001;p>0.05 compared to baseline
Summary
A significant reduction in Alkaline, EndoIII and FPG DNA damage post intervention in the treatment group
Placebo DNA damage levels significantly increased from baseline
Conclusion
These data show for the first time that physiological levels of a novel supplement reduces levels of DNA damage
This novel treatment had a protective effect on the patient blood levels of DNA damage
In addition, the most significant reduction in DNA damage levels was observed in those patients with higher baseline levels
Additional research is urgently required
Acknowledgements Supported by grant from WHCST Amgen / Irish Nephrological Society Research
Award
Thanks to the research group: Dr Peter Garrett Ms Twyla Moffitt
Supplement Prescription: Patent Protected Supplement Dose Vitamin C (ascorbate) 60mg Vitamin E (tocopherol) 10mg Vitamin K 65g Folic acid (mg) 800g B2 Riboflavin (mg) 1.6mg *B6 (mg) 10mg *B12 (g) 12 g B5 (Pantothenic acid, mg) 1mg B1 Thiamin (mg) 1mg Zinc 15mg Copper 1.5mg Selenium 75g